Full text is available at the source.
Preoperative weight loss with glucagon‐like peptide‐1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis
Weight loss before surgery using a diabetes drug predicts more weight loss after combined medical treatment and weight surgery in type 2 diabetes patients
AI simplified
Abstract
The median weight loss from the start of medical weight management until 12 months post-surgery was 17.9%.
- Weight loss during GLP-1 receptor agonist treatment was 5.0%.
- Weight loss after GLP-1RA treatment predicted weight loss from medical weight management until 12 months post-surgery.
- Postoperative weight loss was not predicted by weight loss during GLP-1RA treatment after adjustments.
- A negative association was found between the proportion of weight loss attributed to GLP-1RA treatment and that attributed to surgery.
AI simplified